This forum is for questions and support regarding ovarian cancer issues, such as: Biopsy, Chemotherapy, Clinical Trials, Genetics, Hysterectomy, Immunotherapy, Ovarian Cancer Types, Radiation Therapy, Risk Factors, Screening, Staging, Surgery.
I was having carboplatin two years after the first round of infusion. On the fourth infusion I went into cardiac arrest as a result of an allergic reaction. Now I will be trying topotecan. Do you have any other suggestions? I had few mild side effects from the carboplatin.
thank you for your question. topotecan is a great choice and has a good track record for the treatment of ovarian cancer.
other choices of chemo include but are not limited to:
weekly low dose taxol
also if carboplatin is working, another choice is to use the carboplatin with a desensitization protocol for allergy.
This is usually done as an inpatient with consultation with an allergist.You should ask your oncologist if they have a protocol for this. I have pasted one article on this but there are many studies looking at desensitization .
J Investig Allergol Clin Immunol. 2011;21(2):108-12.
A new rapid desensitization protocol for chemotherapy agents.
Gastaminza G, de la Borbolla JM, Goikoetxea MJ, Escudero R, Antón J, Espinós J, Lacasa C, Fernández-Benítez M, Sanz ML, Ferrer M.
Department of Allergology and Clinical Immunology, Clinica Universidad de Navarra, Pamplona, Spain. ***@****
Desensitization has been used for some decades to treat patients with the allergenic drug when an alternative drug with similar efficacy and safety is not available. We present the results from a series of oncology patients desensitized at our hospital during the last 2 years.
To assess the efficacy of a new desensitization protocol in patients allergic to chemotherapy drugs.
We performed an observational retrospective study of 11 women (6 breast cancer and 5 ovarian cancer) who underwent our desensitization protocol. Four patients had immediate reactions to carboplatin, 3 to docetaxel, 3 to paclitaxel, and 1 to both docetaxel and paclitaxel. Premedication was administered in all cases. A 5-step protocol based on 5 different dilutions of the drugs was used.
We performed 39 desensitization procedures: 14 to carboplatin, 3 to oxaliplatin, 16 to docetaxel, and 6 to paclitaxel. Eight patients tolerated the full dose in 36 procedures. One patient suffered an anaphylactic reaction to carboplatin that reverted with treatment. One patient had dyspnea after a paclitaxel cycle. One patient experienced dyspnea due to chronic pulmonary thromboembolism related to her disease.
Desensitization is a useful procedure in patients who are allergic to their chemotherapy agents.
Copyright 1994-2016 MedHelp International. All rights reserved.
MedHelp is a division of Aptus Health.
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.